Two Poems
Release time:
2020-08-14
Poem 2
■ Beishan Woodcutter
Enters Qiao Lu
Bingshen Enters Qiao Lu on the 8th of August. Four years of hard work and positive results finally become Yin
After 50 years of wind and rain, the old residence's humble room was deformed early.
Watt back is sparse and often leaks rain, and the ground is wet and damp.
The old man has nothing to do with his leisure, so he can rebuild the dilapidated house.
Destroy the old house and plan to build a woodcutter.
Three Volts Started to Top the Glory Day, Cold Winter to Top the Ice.
Red brick cement sand and gravel, rammed base masonry wall reinforcement.
The old mother helped cook tea, and the young girl drove the miscellaneous zeros.
The decoration is complicated and tight, and the piles are detailed.
Limited banknotes seek perfection and have no intention of competing for a thin name.
study sips tea in leisure time, and the courtyard is full of vitality to enjoy the new scenery.
Autumn Wind Frequently Satisfied, Jin Guizhi Head Flower Lei Meng.
You should know enough about your pride in life. True water has no fragrance and can be evaluated (Note).
Note: When Yu 65 was old, Mr. Wu Zhanbao, former vice chairman of the Municipal Committee of the Chinese People's Political Consultative Conference, presented a "True Water Without Fragrance" screen, which is now hanging indoors.
Qiao Lu courtyard a glimpse of
Qiao Lu square built, courtyard background new.
yellow wall decorated with red tiles, moss point stone path.
has laurel trees and green trees, scattered with gold everywhere.
Taxus chinensis stands in the south and Luohan pine stands in the north.
hollyhock with impatiens, bright red hybrid powder.
camellia hexagonal red, different plum famous triangle.
The garden is full of Diaolan and ranks among evergreen.
Seek rocks into streams and visit Huawu Riverside.
fertilizer and water often care, cold and hot care.
Sunset Castle Peak Back, Flowers and Trees with the rest of my life.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31